119
Maternity and Obstetrics
Figure 3: Non-Invasive Prenatal Testing increasing since its introduction in 2013
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Maternal age
10 14 10 2 3 3 0 1 2 0
Abnormal fetal ultrasound
86 97 82 87 83 74 79 103 113 106
Positive screening test
47 41 59 40 31 37 45 37 36 44
Previous chromosomal
abnormality/carrier of
translocation
18 20 22 10 11 16 10 6 9 3
Previous non-chromosomal
genetic syndrome
23 19 23 18 12 13 12 9 8 8
Miscellaneous
16 9 14 5 5 4 2 13 7 6
Total
200 200 210 162 145 147 148 169 175
167
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Trisomy 21
27 22 26 31 23 28 33 28 39 39
Trisomy 18
20 15 13 13 18 17 18 15 23 22
Trisomy 13
7 9 8 9 4 5 1 8 8 9
Other aneuploidies
14 16 9 11 16 6 10 17 19 9
Non chromosomal genetic
abnormality
5 6 8 5 3 8 3 2 0 4
Total
73 68 61 69 64 64 65 70 89 83
Table 2: Indication for Prenatal Diagnosis (Amniocentesis and CVS)
2500
2000
1500
1000
500
0
2013 2014 2015 2016 2017 2018 2019 2020
Table 3: Abnormalities Detected by Prenatal Testing
NMH Annual Rep t
|
2020
